Your session is about to expire
← Back to Search
Harmine Hydrochloride Capsules for Diabetes
Study Summary
This trial is testing how much of the drug harmine healthy volunteers can tolerate. The goal is to find the maximum dose that is safe.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
How many volunteers are being recruited for this clinical trial?
"Affirmative. Clinicaltrials.gov confirms that this research venture, which was initially advertised on September 13th 2022, is in the process of enrolling patients. 40 individuals need to be recruited from 1 medical facility."
What criteria must be met in order to qualify for this experiment?
"This research is enrolling 40 individuals aged 18-55 with a BMI between 19 and 30 who suffer from diabetes mellitus. As part of the admittance criteria, participants must be able to communicate in English effectively enough to agree to tests or examinations as well as understand the consent process. Additionally, both male and female applicants are encouraged to utilize an accepted contraceptive method throughout this trial while women should not partake if they are breastfeeding."
Are senior citizens included in the parameters of this investigation?
"This research seeks participants who are between 18 and 55 years of age."
Is this experiment in need of additional participants at the present time?
"As per the information presented on clinicaltrials.gov, this trial is presently looking for volunteers. The experiment was first announced on September 13th 2022 and its most recent update was issued on October 28th of that same year."
What risks should be considered prior to taking Harmine Hydrochloride Capsules?
"The safety rating of Harmine Hydrochloride Capsules is 1, as this trial is in the early Phase 1 stage where there has been limited research conducted into its efficacy and security."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger